Necessity of harvesting at least 25 lymph nodes in patients with stage n2-n3 resectable gastric cancer a 10-year, single-institution cohort study

Medicine (United States)

Volumn 94, Issue 10, 2015, Pages

  Chen, Hai Ning ^a   Chen, Xin Zu ^a,b   Zhang, Wei Han ^a   Chen, Xiao Long ^a   Yang, Kun ^a,b   Liu, Jian Ping ^a   Zhang, Bo ^a   Chen, Zhi Xin ^a   Chen, Jia Ping ^a   Zhou, Zong Guang ^a   Hu, Jian Kun ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL ABSCESS; ABDOMINAL BLEEDING; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; AORTODUODENAL FISTULA; ARTICLE; BILE DUCT FISTULA; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISTANT METASTASIS; FEMALE; FOLLOW UP; GASTRECTOMY; GASTROINTESTINAL HEMORRHAGE; HAZARD RATIO; HEART ARRHYTHMIA; HEART FAILURE; HIGH VOLUME HOSPITAL; HUMAN; ILEUS; KIDNEY FAILURE; LIVER FAILURE; LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NAUSEA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERSONAL EXPERIENCE; PLEURA EFFUSION; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSTIC ASSESSMENT; SEPSIS; STOMACH CANCER; STOMACH PARESIS; SURGICAL TECHNIQUE; TREATMENT DURATION; URINARY TRACT INFECTION; WOUND INFECTION; ADVERSE EFFECTS; COHORT ANALYSIS; LABORATORY DIAGNOSIS; LENGTH OF STAY; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; STANDARDS; STOMACH NEOPLASMS; SURVIVAL; TRANSPLANTATION;

COHORT STUDIES; GASTRECTOMY; HUMANS; LENGTH OF STAY; LYMPH NODE EXCISION; LYMPH NODES; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SPECIMEN HANDLING; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TISSUE AND ORGAN HARVESTING;

EID: 84929031164     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000620     Document Type: Article

References (22)

1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr, accessed on 14/August/2014.
2. Edge SB, Byrd DR, Compton CC. AJCC Cancer Staging Manual. 7th ed. New York, Dordrecht, Heidelberg, London: Springer; 2010.
3. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Gastric Cancer. Version 1.2014. 2014. Accessed August 8, 2014, 2014.
4. Songun I, Putter H, Kranenbarg EM, et al. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11:439-449.
5. Baiocchi GL, Tiberio GA, Minicozzi AM, et al. A multicentric Western analysis of prognostic factors in advanced, node-negative gastric cancer patients. Ann Surg. 2010;252:70-73.
6. Smith DD, Schwarz RR, Schwarz RE. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol. 2005;23:7114-7124.
7. Schwarz RE, Smith DD. Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage. Ann Surg Oncol. 2007;14:317-328.
8. Japanese Gastric Cancer A. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14:113-123.
9. Chen XZ, Yang K, Zhang B, et al. Is retrieval of >25 lymph nodes a superior criterion for locally advanced gastric cancer surgery? Ann Surg. 2011;254:834-835author reply 835.
10. Japanese Gastric Cancer A. Japanese classification of gastric carcinoma: 3rd English edition. Gastric cancer. 2011;14:101-112.
11. Bruin J. Survival Analysis with Stata, UCLA: Statistical Consulting Group. Available from: http://www.ats.ucla.edu/STAT/stata/seminars/stata-survival/. Accessed August 14, 2014.
12. Biffi R, Botteri E, Cenciarelli S, et al. Impact on survival of the number of lymph nodes removed in patients with node-negative gastric cancer submitted to extended lymph node dissection. Eur J Surg Oncol. 2011;37:305-311.
13. Hirabayashi S, Kosugi S, Isobe Y, et al. Development and external validation of a nomogram for overall survival after curative resection in serosa-negative, locally advanced gastric cancer. Ann Oncol. 2014;25:1179-1184.
14. Saito T, Kurokawa Y, Takiguchi S, et al. Accuracy of multidetectorrow CT in diagnosing lymph node metastasis in patients with gastric cancer. Eur Radiol. 2015;25:368-374.
15. Chen CY, Hsu JS, Wu DC, et al. Gastric cancer: preoperative local staging with 3D multi-detector row CT-correlation with surgical and histopathologic results. Radiology. 2007;242:472-482.
16. Kim HJ, Kim AY, Oh ST, et al. Gastric cancer staging at multidetector row CT gastrography: comparison of transverse and volumetric CT scanning. Radiology. 2005;236:879-885.
17. Hu JK, Yang K, Zhang B, et al. D2 plus para-aortic lymphadenectomy versus standardized D2 lymphadenectomy in gastric cancer surgery. Surg Today. 2009;39:207-213.
18. Chen XZ, Hu JK, Zhou ZG, et al. Meta-analysis of effectiveness and safety of D2 plus para-aortic lymphadenectomy for resectable gastric cancer. J Am Col Surg. 2010;210:100-105.
19. Memon MA, Subramanya MS, Khan S, et al. Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma. Ann Surg. 2011;253:900-911.
20. Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer. 1999;79:1522-1530.
21. Enzinger PC, Benedetti JK, Meyerhardt JA, et al. Impact of hospital volume on recurrence and survival after surgery for gastric cancer. Ann Surg. 2007;245:426-434.
22. Siewert JR, Bottcher K, Stein HJ, et al. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg. 1998;228:449-461.